Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated donor umbilical cord blood transplantation with myeloablative conditioning for haematological diseases
2009-011818-21Phase 2Terminated
- Sponsor
- University College London
- Start
- Jun 2010
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide, fludarabine, busulfan and melphalan in Hematopathy, sponsored by University College London. Primary endpoint: Non-relapse mortality at day 100. Started Jun 2010; status: terminated.
02
Drugs
cyclophosphamidefludarabinebusulfanmelphalan
03
Conditions
Hematopathy
Beyond the preview
Go deeper on 2009-011818-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011818-21.